The MarketWatch News Department was not involved in the creation of this content. BOLOGNA, Italy and MUNICH, Jan. 14, 2026 /PRNewswire/ -- Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical ...
The study included adults with HSV encephalitis admitted to UK hospitals who were randomly assigned to receive intravenous dexamethasone plus intravenous acyclovir or intravenous acyclovir alone ...
The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and ...
This case illustrates many of the diagnostic challenges that may be encountered in patients presenting with herpes simplex infection of the brain. The patient had presented with transient focal ...
The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists. The herpes simplex virus-1 can ...
A combination of anti-inflammatory and antiviral agents could improve treatment of encephalitis caused by herpes simplex virus-1 (HSV-1), according to new research utilizing cerebral organoids. A ...
BOLOGNA, Italy and MUNICH, Jan. 14, 2026 /PRNewswire/ -- Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results